Respiratory Viral Infection clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

    open to eligible people ages 18-65

    Open label clinical trial of persons (adults) that will determine the safety and efficacy of the diet supplement oral mitoquinone/mitoquinol mesylate (Mito-MES) to prevent the development and progression of severe viral infections like COVID-19 after high-risk exposure to a person with possible respiratory viral infection such as SARS-CoV-2 infection in persons who will receive Mito-MES compared to persons who will not receive Mito-MES (controls).

    at UCLA

Our lead scientists for Respiratory Viral Infection research studies include .

Last updated: